Veeva Systems (VEEV) is a premier provider of cloud solutions for the global life sciences industry, covering R&D to commercialization. Despite potential competition from Salesforce and high valuation ...

In December 2025, Veeva Systems’ board appointed longtime finance leader Vipin Kondath as principal accounting officer, formalizing his oversight of the company’s financial reporting and controls ...

Veeva Systems Inc. (NYSE:VEEV) is one of the best healthcare AI stocks to buy now. On December 15, Stifel reiterated a Buy ...

Veeva Systems is performing well and demonstrating strong management execution, making it a buy. The company's R&D solutions and Veeva Vault CRM migration are key factors for future growth. Veeva's ...

Investing.com - KeyBanc downgraded Veeva Systems (NYSE:VEEV) from Overweight to Sector Weight on Friday, citing increased competitive pressure from Salesforce’s life sciences offerings. The downgrade ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid second-quarter fiscal 2025 performance and strategic ...

During the last three months, 15 analysts shared their evaluations of Veeva Systems (NYSE:VEEV), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ...

Veeva offers critical software to the life sciences industry. A superior product gives it a great advantage over the competition. Its newest segment could help the company outperform over the next 10 ...

Veeva Systems reported third-quarter revenue of US$811.24 million and net income of US$236.2 million, both above prior-year results, and raised its guidance for fiscal 2026 revenue to between US$3.17 ...

Top-line growth rates at the cloud computing company have dropped recently. Still, Veeva's prospects remain intact for investors focused on the long game. The life sciences-focused, cloud-based ...